This topic contains a solution. Click here to go to the answer

Author Question: At least in part, synaptic concentrations of endocannabinoids are regulated by presynaptic reuptake. ... (Read 36 times)

bb

  • Hero Member
  • *****
  • Posts: 544
At least in part, synaptic concentrations of endocannabinoids are regulated by presynaptic reuptake.
 
  a. True.
  b. False.

Question 2

Because it has its own endogenous receptor system, marijuana does not appear to involve mesocorticolimbic dopamine neurons.
 
  a. True.
  b. False.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sweetkitty24130

  • Sr. Member
  • ****
  • Posts: 291
Answer to Question 1

True

Answer to Question 2

False




bb

  • Member
  • Posts: 544
Reply 2 on: Jun 22, 2018
Gracias!


adf223

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library